Programmatic challenges in managing multidrug-resistant tuberculosis in Malawi
- PMID: 34494563
- PMCID: PMC8542254
- DOI: 10.4103/ijmy.ijmy_47_21
Programmatic challenges in managing multidrug-resistant tuberculosis in Malawi
Abstract
Background: Multidrug-resistant tuberculosis (MDR-TB) is one of the most urgent challenges that Malawi tends to take a firm public health action. A recent increase in multidrug MDR-TB cases, a decrease in treatment success rate, and a double increase of lost-to-follow-up call into question the country's programmatic management of MDR-TB (PMDT). As such, the study aimed at exploring programmatic challenges in managing MDR-TB in Malawi.
Methods: A comprehensive and nonsystematic search was made in PubMed and Google Scholar using mainly the keywords "MDR-TB" "extensively drug-resistant TB," Malawi. The study reviewed existing guidelines and gray literature and reviewed data obtained from the national TB program (NTP) as well.
Results: The study found the following challenges affecting PMDT: decrease in funding, partial access to GeneXpert, delay in diagnosis, long treatment duration, lack of adequate personal protective equipment, the long turnaround time of culture results, failure to initiate all diagnosed patients on treatment, absence of alternative second-line medicines, and lack of transport from health facilities to patient homes.
Conclusion: If the Malawi NTP is to achieve a vision of a "TB-free Malawi," rigorous efforts at all levels must be made, including mobilizing domestic resources for improved MDR-TB program performance. Developing partners should continue providing the much-needed funding to the Malawi government to stand in the wake of the MDR-TB crisis.
Keywords: Extensively drug-resistant tuberculosis; Malawi; multidrug-resistant tuberculosis; programmatic management.
Conflict of interest statement
None
Figures
Similar articles
-
Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and Treatment.Infect Dis Clin North Am. 2019 Dec;33(4):1063-1085. doi: 10.1016/j.idc.2019.09.002. Infect Dis Clin North Am. 2019. PMID: 31668191 Review.
-
Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.Infect Genet Evol. 2012 Jun;12(4):686-94. doi: 10.1016/j.meegid.2011.07.019. Epub 2011 Aug 4. Infect Genet Evol. 2012. PMID: 21839855 Review.
-
Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43. MMWR Recomm Rep. 2009. PMID: 19214162
-
Management of multidrug resistant tuberculosis.Semin Respir Crit Care Med. 2013 Feb;34(1):44-59. doi: 10.1055/s-0032-1333546. Epub 2013 Mar 4. Semin Respir Crit Care Med. 2013. PMID: 23460005 Review.
-
Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.BMC Infect Dis. 2017 Sep 29;17(1):655. doi: 10.1186/s12879-017-2746-5. BMC Infect Dis. 2017. PMID: 28962599 Free PMC article.
Cited by
-
Effect of Digital Medication Event Reminder and Monitor-Observed Therapy vs Standard Directly Observed Therapy on Health-Related Quality of Life and Catastrophic Costs in Patients With Tuberculosis: A Secondary Analysis of a Randomized Clinical Trial.JAMA Netw Open. 2022 Sep 15;5(9):e2230509. doi: 10.1001/jamanetworkopen.2022.30509. JAMA Netw Open. 2022. PMID: 36107429 Free PMC article. Clinical Trial.
-
Patterns of childhood tuberculosis diagnosis in Ethiopia: A multicenter cross-sectional study.Res Sq [Preprint]. 2023 Dec 29:rs.3.rs-3758745. doi: 10.21203/rs.3.rs-3758745/v1. Res Sq. 2023. PMID: 38234744 Free PMC article. Preprint.
-
Impact of early chest radiography on delay in pulmonary tuberculosis case notification in Ethiopia.Int J Mycobacteriol. 2021 Oct-Dec;10(4):364-372. doi: 10.4103/ijmy.ijmy_216_21. Int J Mycobacteriol. 2021. PMID: 34916453 Free PMC article.
-
Molecular Dynamic Simulations and Molecular Docking as a Potential Way for Designed New Inhibitor Drug without Resistance.Tanaffos. 2022 Jan;21(1):1-14. Tanaffos. 2022. PMID: 36258912 Free PMC article. Review.
-
"I Do Not Believe We Should Disclose Everything to an Older Patient": Challenges and Ethical Concerns in Clinical Decision-Making in Old-Age Care in Ethiopia.Health Care Anal. 2024 Dec;32(4):290-311. doi: 10.1007/s10728-024-00494-y. Epub 2024 Oct 1. Health Care Anal. 2024. PMID: 39354236 Free PMC article.
References
-
- Kumar A, Singh A, Upadhyay V, Pandey J. Epidemiology of multi-drug-resistant tuberculosis in Northern India. Biomed Biotechnol Res J 2018;2:112.
-
- World Health Organization. Global Tuberculosis Report 2020. Geneva: World Health Organization; 2020.
-
- World Health Organization. The End TB Strategy. Geneva: World Health Organization; 2012.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous